- IBDEI2FD ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,38740,1,3,0)
- ;;=3^Heart Failure,Diastolic,Chronic
- ;;^UTILITY(U,$J,358.3,38740,1,4,0)
- ;;=4^I50.32
- ;;^UTILITY(U,$J,358.3,38740,2)
- ;;=^5007245
- ;;^UTILITY(U,$J,358.3,38741,0)
- ;;=I50.42^^152^1985^36
- ;;^UTILITY(U,$J,358.3,38741,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38741,1,3,0)
- ;;=3^Heart Failure,Systolic & Diastolic,Chronic
- ;;^UTILITY(U,$J,358.3,38741,1,4,0)
- ;;=4^I50.42
- ;;^UTILITY(U,$J,358.3,38741,2)
- ;;=^5007249
- ;;^UTILITY(U,$J,358.3,38742,0)
- ;;=I13.0^^152^1985^30
- ;;^UTILITY(U,$J,358.3,38742,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38742,1,3,0)
- ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
- ;;^UTILITY(U,$J,358.3,38742,1,4,0)
- ;;=4^I13.0
- ;;^UTILITY(U,$J,358.3,38742,2)
- ;;=^5007067
- ;;^UTILITY(U,$J,358.3,38743,0)
- ;;=I13.2^^152^1985^31
- ;;^UTILITY(U,$J,358.3,38743,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38743,1,3,0)
- ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
- ;;^UTILITY(U,$J,358.3,38743,1,4,0)
- ;;=4^I13.2
- ;;^UTILITY(U,$J,358.3,38743,2)
- ;;=^5007070
- ;;^UTILITY(U,$J,358.3,38744,0)
- ;;=I13.10^^152^1985^32
- ;;^UTILITY(U,$J,358.3,38744,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38744,1,3,0)
- ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
- ;;^UTILITY(U,$J,358.3,38744,1,4,0)
- ;;=4^I13.10
- ;;^UTILITY(U,$J,358.3,38744,2)
- ;;=^5007068
- ;;^UTILITY(U,$J,358.3,38745,0)
- ;;=I13.11^^152^1985^33
- ;;^UTILITY(U,$J,358.3,38745,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38745,1,3,0)
- ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
- ;;^UTILITY(U,$J,358.3,38745,1,4,0)
- ;;=4^I13.11
- ;;^UTILITY(U,$J,358.3,38745,2)
- ;;=^5007069
- ;;^UTILITY(U,$J,358.3,38746,0)
- ;;=E03.9^^152^1985^43
- ;;^UTILITY(U,$J,358.3,38746,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38746,1,3,0)
- ;;=3^Hypothyroidism,Unspec
- ;;^UTILITY(U,$J,358.3,38746,1,4,0)
- ;;=4^E03.9
- ;;^UTILITY(U,$J,358.3,38746,2)
- ;;=^5002476
- ;;^UTILITY(U,$J,358.3,38747,0)
- ;;=M54.5^^152^1985^46
- ;;^UTILITY(U,$J,358.3,38747,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38747,1,3,0)
- ;;=3^Low Back Pain
- ;;^UTILITY(U,$J,358.3,38747,1,4,0)
- ;;=4^M54.5
- ;;^UTILITY(U,$J,358.3,38747,2)
- ;;=^5012311
- ;;^UTILITY(U,$J,358.3,38748,0)
- ;;=C61.^^152^1985^47
- ;;^UTILITY(U,$J,358.3,38748,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38748,1,3,0)
- ;;=3^Malig Neopl Prostate
- ;;^UTILITY(U,$J,358.3,38748,1,4,0)
- ;;=4^C61.
- ;;^UTILITY(U,$J,358.3,38748,2)
- ;;=^267239
- ;;^UTILITY(U,$J,358.3,38749,0)
- ;;=F11.20^^152^1985^53
- ;;^UTILITY(U,$J,358.3,38749,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38749,1,3,0)
- ;;=3^Opioid Dependence,Uncomplicated
- ;;^UTILITY(U,$J,358.3,38749,1,4,0)
- ;;=4^F11.20
- ;;^UTILITY(U,$J,358.3,38749,2)
- ;;=^5003127
- ;;^UTILITY(U,$J,358.3,38750,0)
- ;;=M19.90^^152^1985^54
- ;;^UTILITY(U,$J,358.3,38750,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38750,1,3,0)
- ;;=3^Osteoarthritis,Unspec
- ;;^UTILITY(U,$J,358.3,38750,1,4,0)
- ;;=4^M19.90
- ;;^UTILITY(U,$J,358.3,38750,2)
- ;;=^5010853
- ;;^UTILITY(U,$J,358.3,38751,0)
- ;;=M85.80^^152^1985^55
- ;;^UTILITY(U,$J,358.3,38751,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38751,1,3,0)
- ;;=3^Osteopenia,Unspec Site
- ;;^UTILITY(U,$J,358.3,38751,1,4,0)
- ;;=4^M85.80
- ;;^UTILITY(U,$J,358.3,38751,2)
- ;;=^5014473
- ;;^UTILITY(U,$J,358.3,38752,0)
- ;;=M81.0^^152^1985^56
- ;;^UTILITY(U,$J,358.3,38752,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,38752,1,3,0)
- ;;=3^Osteoporosis,Age-Related w/o Fx
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2FD 3765 printed Feb 18, 2025@23:54:06 Page 2
- IBDEI2FD ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,38740,1,3,0)
- +2 ;;=3^Heart Failure,Diastolic,Chronic
- +3 ;;^UTILITY(U,$J,358.3,38740,1,4,0)
- +4 ;;=4^I50.32
- +5 ;;^UTILITY(U,$J,358.3,38740,2)
- +6 ;;=^5007245
- +7 ;;^UTILITY(U,$J,358.3,38741,0)
- +8 ;;=I50.42^^152^1985^36
- +9 ;;^UTILITY(U,$J,358.3,38741,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,38741,1,3,0)
- +12 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
- +13 ;;^UTILITY(U,$J,358.3,38741,1,4,0)
- +14 ;;=4^I50.42
- +15 ;;^UTILITY(U,$J,358.3,38741,2)
- +16 ;;=^5007249
- +17 ;;^UTILITY(U,$J,358.3,38742,0)
- +18 ;;=I13.0^^152^1985^30
- +19 ;;^UTILITY(U,$J,358.3,38742,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,38742,1,3,0)
- +22 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
- +23 ;;^UTILITY(U,$J,358.3,38742,1,4,0)
- +24 ;;=4^I13.0
- +25 ;;^UTILITY(U,$J,358.3,38742,2)
- +26 ;;=^5007067
- +27 ;;^UTILITY(U,$J,358.3,38743,0)
- +28 ;;=I13.2^^152^1985^31
- +29 ;;^UTILITY(U,$J,358.3,38743,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,38743,1,3,0)
- +32 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
- +33 ;;^UTILITY(U,$J,358.3,38743,1,4,0)
- +34 ;;=4^I13.2
- +35 ;;^UTILITY(U,$J,358.3,38743,2)
- +36 ;;=^5007070
- +37 ;;^UTILITY(U,$J,358.3,38744,0)
- +38 ;;=I13.10^^152^1985^32
- +39 ;;^UTILITY(U,$J,358.3,38744,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,38744,1,3,0)
- +42 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
- +43 ;;^UTILITY(U,$J,358.3,38744,1,4,0)
- +44 ;;=4^I13.10
- +45 ;;^UTILITY(U,$J,358.3,38744,2)
- +46 ;;=^5007068
- +47 ;;^UTILITY(U,$J,358.3,38745,0)
- +48 ;;=I13.11^^152^1985^33
- +49 ;;^UTILITY(U,$J,358.3,38745,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,38745,1,3,0)
- +52 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
- +53 ;;^UTILITY(U,$J,358.3,38745,1,4,0)
- +54 ;;=4^I13.11
- +55 ;;^UTILITY(U,$J,358.3,38745,2)
- +56 ;;=^5007069
- +57 ;;^UTILITY(U,$J,358.3,38746,0)
- +58 ;;=E03.9^^152^1985^43
- +59 ;;^UTILITY(U,$J,358.3,38746,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,38746,1,3,0)
- +62 ;;=3^Hypothyroidism,Unspec
- +63 ;;^UTILITY(U,$J,358.3,38746,1,4,0)
- +64 ;;=4^E03.9
- +65 ;;^UTILITY(U,$J,358.3,38746,2)
- +66 ;;=^5002476
- +67 ;;^UTILITY(U,$J,358.3,38747,0)
- +68 ;;=M54.5^^152^1985^46
- +69 ;;^UTILITY(U,$J,358.3,38747,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,38747,1,3,0)
- +72 ;;=3^Low Back Pain
- +73 ;;^UTILITY(U,$J,358.3,38747,1,4,0)
- +74 ;;=4^M54.5
- +75 ;;^UTILITY(U,$J,358.3,38747,2)
- +76 ;;=^5012311
- +77 ;;^UTILITY(U,$J,358.3,38748,0)
- +78 ;;=C61.^^152^1985^47
- +79 ;;^UTILITY(U,$J,358.3,38748,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,38748,1,3,0)
- +82 ;;=3^Malig Neopl Prostate
- +83 ;;^UTILITY(U,$J,358.3,38748,1,4,0)
- +84 ;;=4^C61.
- +85 ;;^UTILITY(U,$J,358.3,38748,2)
- +86 ;;=^267239
- +87 ;;^UTILITY(U,$J,358.3,38749,0)
- +88 ;;=F11.20^^152^1985^53
- +89 ;;^UTILITY(U,$J,358.3,38749,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,38749,1,3,0)
- +92 ;;=3^Opioid Dependence,Uncomplicated
- +93 ;;^UTILITY(U,$J,358.3,38749,1,4,0)
- +94 ;;=4^F11.20
- +95 ;;^UTILITY(U,$J,358.3,38749,2)
- +96 ;;=^5003127
- +97 ;;^UTILITY(U,$J,358.3,38750,0)
- +98 ;;=M19.90^^152^1985^54
- +99 ;;^UTILITY(U,$J,358.3,38750,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,38750,1,3,0)
- +102 ;;=3^Osteoarthritis,Unspec
- +103 ;;^UTILITY(U,$J,358.3,38750,1,4,0)
- +104 ;;=4^M19.90
- +105 ;;^UTILITY(U,$J,358.3,38750,2)
- +106 ;;=^5010853
- +107 ;;^UTILITY(U,$J,358.3,38751,0)
- +108 ;;=M85.80^^152^1985^55
- +109 ;;^UTILITY(U,$J,358.3,38751,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,38751,1,3,0)
- +112 ;;=3^Osteopenia,Unspec Site
- +113 ;;^UTILITY(U,$J,358.3,38751,1,4,0)
- +114 ;;=4^M85.80
- +115 ;;^UTILITY(U,$J,358.3,38751,2)
- +116 ;;=^5014473
- +117 ;;^UTILITY(U,$J,358.3,38752,0)
- +118 ;;=M81.0^^152^1985^56
- +119 ;;^UTILITY(U,$J,358.3,38752,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,38752,1,3,0)
- +122 ;;=3^Osteoporosis,Age-Related w/o Fx